PFM Health Sciences’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,944
| Closed | -$529K | – | 110 |
|
|
2017
Q3 | $529K | Sell |
2,944
-1,740,407
| -100% | -$243M | 0.01% | 86 |
|
|
2017
Q2 | $181M | Buy |
1,743,351
+897,958
| +106% | +$73.3M | 4.87% | 1 |
|
|
2017
Q1 | $66.4M | Sell |
845,393
-152,071
| -15% | -$9.4M | 1.66% | 20 |
|
|
2016
Q4 | $44.7M | Buy |
997,464
+496,378
| +99% | +$24.3M | 1.26% | 26 |
|
|
2016
Q3 | $28M | Buy |
501,086
+189,321
| +61% | +$10.5M | 0.82% | 48 |
|
|
2016
Q2 | $15.6M | Sell |
311,765
-2,000
| -0.6% | -$98.3K | 0.47% | 61 |
|
|
2016
Q1 | $14.4M | Sell |
313,765
-242,668
| -44% | -$11.8M | 0.44% | 55 |
|
|
2015
Q4 | $34.3M | Sell |
556,433
-126,144
| -18% | -$8.88M | 1.04% | 37 |
|
|
2015
Q3 | $38M | Buy |
682,577
+373,425
| +121% | +$23.5M | 1.07% | 36 |
|
|
2015
Q2 | $18.8M | Buy |
309,152
+133,158
| +76% | +$7.6M | 0.48% | 59 |
|
|
2015
Q1 | $10.2M | Sell |
175,994
-40,658
| -19% | -$2.72M | 0.28% | 71 |
|
|
2014
Q4 | $12.5M | Buy |
+216,652
| New | +$9.12M | 0.29% | 74 |
|
PFM Health Sciences's KITE Position: Q4 2017 in Review
PFM Health Sciences sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 2,944 shares — an estimated $529K sold.
PFM Health Sciences first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $181M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- PFM Health Sciences reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- PFM Health Sciences sold 2,944 Kite Pharma, Inc. shares in Q4 2017, an estimated $529K.
- PFM Health Sciences first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
- PFM Health Sciences's Kite Pharma, Inc. position peaked at $181M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.